Moxigram DM Eye Drops 5ml represent a sophisticated ophthalmic solution engineered to address both bacterial infections and associated inflammation in a single formulation. This st...

Moxigram DM Eye Drops 5ml represent a sophisticated ophthalmic solution engineered to address both bacterial infections and associated inflammation in a single formulation. This sterile eye drop combines Moxifloxacin Hydrochloride 0.5% w/v, a potent broad-spectrum fluoroquinolone antibiotic, with Dexamethasone Sodium Phosphate 0.1% w/v, a powerful corticosteroid. The dual-action approach ensures comprehensive treatment by simultaneously eliminating pathogenic bacteria while controlling the inflammatory response that causes discomfort, redness, and swelling. Manufactured under strict quality controls, this 5ml presentation maintains sterility throughout usage and offers a practical 24-month shelf life when stored at temperatures below 25°C, providing healthcare providers with a reliable therapeutic option for various ocular conditions. This advanced ophthalmic formulation finds extensive application across multiple healthcare settings, particularly in ophthalmology clinics, hospitals, and surgical centers. Medical professionals routinely prescribe Moxigram DM for bacterial conjunctivitis cases presenting with significant inflammation, post-operative care following cataract and refractive surgeries, and treatment of corneal infections like bacterial keratitis. The product serves as a cornerstone in managing blepharitis complicated by bacterial infection and inflammation, while also being valuable in emergency departments for ocular trauma cases requiring both antibiotic coverage and inflammation control. Its consistent performance makes it a preferred choice among ophthalmologists, optometrists, and general practitioners dealing with eye care patients. For distribution partners including importers, wholesalers, and healthcare procurement specialists, Moxigram DM Eye Drops deliver substantial value through proven reliability and clinical effectiveness. The product's dual-action formula reduces the need for multiple medications, simplifying treatment regimens for patients and inventory management for healthcare facilities. With stringent manufacturing standards ensuring batch-to-batch consistency and a stable 24-month shelf life, businesses can maintain optimal stock levels without concerns about product degradation. The formulation's effectiveness against common ocular pathogens combined with potent anti-inflammatory action creates strong customer loyalty and repeat purchase patterns, making it a valuable addition to any medical product portfolio serving the ophthalmic pharmaceutical market.

Key Features:
- Contains Moxifloxacin Hydrochloride 0.5% w/v as broad-spectrum antibiotic
- Includes Dexamethasone Sodium Phosphate 0.1% w/v for inflammation control
- Sterile ophthalmic solution in convenient 5ml dropper bottle
- 24-month shelf life ensures long-term product viability
- Storage requirement below 25°C maintains product stability

Benefits:
- Dual-action formula treats infection and inflammation simultaneously
- Reduces treatment complexity by combining two medications in one
- Proven efficacy against common Gram-positive and Gram-negative ocular pathogens
- Rapid relief from redness, swelling, and discomfort associated with eye infections
- Trusted by healthcare professionals for consistent clinical results